Updated Jul 16, 2026
CARREL MICHAEL H has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Michael H. Carrel is a seasoned executive in the medical device industry, currently serving as the President and CEO of AtriCure, Inc. He has extensive experience in leading companies focused on innovative surgical treatments, particularly in the field of atrial fibrillation.
| Role | President, CEO, & Director, Director |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | ATRC | AtriCure, Inc. | A — Grant or award | 636 | $23.78 | $15K |
| 2026-03-09 | ATRC | AtriCure, Inc. | G — Bona-fide gift | 1.0K | $0.00 | |
| 2026-03-09 | ATRC | AtriCure, Inc. | G — Bona-fide gift | 5.0K | $0.00 | |
| 2026-03-03 | ATRC | AtriCure, Inc. | F — Tax withholding / forfeiture | 72.8K | $31.26 | $2.28M |
| 2026-03-03 | ATRC | AtriCure, Inc. | A — Grant or award | 101.3K | $0.00 | |
| 2026-03-03 | ATRC | AtriCure, Inc. | A — Grant or award | 68.6K | $0.00 | |
| 2025-08-08 | ATRC | AtriCure, Inc. | G — Bona-fide gift | 10.0K | $0.00 | |
| 2025-06-30 | ATRC | AtriCure, Inc. | A — Grant or award | 822 | $25.84 | $21K |
| 2024-11-15 | AXNX | Axonics, Inc. | D — Derivative transaction | 17.9K | $71.00 | $1.27M |
Michael H. Carrel is a seasoned executive in the medical device industry, currently serving as the President and CEO of AtriCure, Inc. He has extensive experience in leading companies focused on innovative surgical treatments, particularly in the field of atrial fibrillation.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live CARREL MICHAEL H profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.